172 related articles for article (PubMed ID: 12603524)
1. Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C.
Patel K; Lajoie A; Heaton S; Pianko S; Behling CA; Bylund D; Pockros PJ; Blatt LM; Conrad A; McHutchison JG
J Gastroenterol Hepatol; 2003 Mar; 18(3):253-7. PubMed ID: 12603524
[TBL] [Abstract][Full Text] [Related]
2. Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group.
McHutchison JG; Blatt LM; de Medina M; Craig JR; Conrad A; Schiff ER; Tong MJ
J Gastroenterol Hepatol; 2000 Aug; 15(8):945-51. PubMed ID: 11022838
[TBL] [Abstract][Full Text] [Related]
3. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis.
Parsian H; Rahimipour A; Nouri M; Somi MH; Qujeq D; Fard MK; Agcheli K
J Gastrointestin Liver Dis; 2010 Jun; 19(2):169-74. PubMed ID: 20593050
[TBL] [Abstract][Full Text] [Related]
4. Can serum hyaluronic acid replace simple non-invasive indexes to predict liver fibrosis in HIV/Hepatitis C coinfected patients?
Resino S; Bellón JM; Asensio C; Micheloud D; Miralles P; Vargas A; Catalán P; López JC; Alvarez E; Cosin J; Lorente R; Muñoz-Fernández MA; Berenguer J
BMC Infect Dis; 2010 Aug; 10():244. PubMed ID: 20723207
[TBL] [Abstract][Full Text] [Related]
5. Serum hyaluronic acid reflects the effect of interferon treatment on hepatic fibrosis in patients with chronic hepatitis C.
Yamada M; Fukuda Y; Koyama Y; Nakano I; Urano F; Katano Y; Hayakawa T
J Gastroenterol Hepatol; 1996 Jul; 11(7):646-51. PubMed ID: 8840240
[TBL] [Abstract][Full Text] [Related]
6. Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection.
Wong VS; Hughes V; Trull A; Wight DG; Petrik J; Alexander GJ
J Viral Hepat; 1998 May; 5(3):187-92. PubMed ID: 9658372
[TBL] [Abstract][Full Text] [Related]
7. Predictive accuracy of serum hyaluronic acid as a non-invasive marker of fibrosis in a cohort of multi-transfused Egyptian children with β-thalassaemia major.
El-Shabrawi MH; Zein El Abedin MY; Omar N; Kamal NM; Elmakarem SA; Khattab S; El-Sayed HM; El-Hennawy A; Ali AS
Arab J Gastroenterol; 2012 Jun; 13(2):45-8. PubMed ID: 22980590
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of YKL-40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis C virus infection.
Schiavon LL; Narciso-Schiavon JL; Carvalho Filho RJ; Sampaio JP; Medina-Pestana JO; Lanzoni VP; Silva AE; Ferraz ML
J Viral Hepat; 2008 Sep; 15(9):666-74. PubMed ID: 18482283
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronic acid predicts hepatic fibrosis in children with hepatic disease.
Hartley JL; Brown RM; Tybulewicz A; Hayes P; Wilson DC; Gillett P; McKiernan P
J Pediatr Gastroenterol Nutr; 2006 Aug; 43(2):217-21. PubMed ID: 16877988
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of serum hyaluronic acid as a fibrosis marker in chronic hepatitis C patients treated with interferon-alpha: histological evaluation by a modified histological activity index scoring system.
Ninomiya T; Yoon S; Hayashi Y; Sugano M; Kumon Y; Seo Y; Shimizu K; Kasuga M
J Gastroenterol Hepatol; 1998 Jan; 13(1):68-74. PubMed ID: 9737575
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis marker, YKL-40, in patients with HCV-associated liver disease.
Saitou Y; Shiraki K; Yamanaka Y; Yamaguchi Y; Kawakita T; Yamamoto N; Sugimoto K; Murata K; Nakano T
World J Gastroenterol; 2005 Jan; 11(4):476-81. PubMed ID: 15641129
[TBL] [Abstract][Full Text] [Related]
12. Correlation between Serum Hyaluronic Acid with Steatosis, Non alcoholic Steato-hepatitis and Fibrosis in Patients with Chronic Hepatitis C Virus Infection.
Mahmoud HS; Ghweil AAS; Osman GS; Ezz-Eldin S Bazeed S; Helal MM
Trop Gastroenterol; 2016; 37(2):93-100. PubMed ID: 30234278
[TBL] [Abstract][Full Text] [Related]
13. The predictive value of noninvasive serum markers of liver fibrosis in patients with chronic hepatitis C.
Gökcan H; Kuzu UB; Öztaş E; Saygılı F; Öztuna D; Suna N; Tenlik İ; Akdoğan M; Kaçar S; Kılıç ZM; Kayaçetin E
Turk J Gastroenterol; 2016 Mar; 27(2):156-64. PubMed ID: 26853790
[TBL] [Abstract][Full Text] [Related]
14. Role of hyaluronic acid and laminin as serum markers for predicting significant fibrosis in patients with chronic hepatitis B.
Li F; Zhu CL; Zhang H; Huang H; Wei Q; Zhu X; Cheng XY
Braz J Infect Dis; 2012; 16(1):9-14. PubMed ID: 22358349
[TBL] [Abstract][Full Text] [Related]
15. Limited reliability of five non-invasive biomarkers in predicting hepatic fibrosis in chronic HCV mono-infected patients opposed to METAVIR scoring.
Elesawy BH; Abd El Hafez A; Dorgham LS; El-Askary A
Pathol Res Pract; 2014 Dec; 210(12):922-8. PubMed ID: 25123964
[TBL] [Abstract][Full Text] [Related]
16. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J
Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.
Sanvisens A; Serra I; Tural C; Tor J; Ojanguren I; Barluenga E; Rey-Joly C; Clotet B; Muga R
J Viral Hepat; 2009 Jul; 16(7):513-8. PubMed ID: 19200132
[TBL] [Abstract][Full Text] [Related]
18. YKL-40 and hyaluronic acid (HA) as noninvasive markers of liver fibrosis in kidney transplant patients with HCV chronic infection.
Schiavon LL; Carvalho-Filho RJ; Narciso-Schiavon JL; Medina-Pestana JO; Lanzoni VP; Ferraz ML; Silva AE
Scand J Gastroenterol; 2010 May; 45(5):615-22. PubMed ID: 20163287
[TBL] [Abstract][Full Text] [Related]
19. Serum hyaluronan: a marker of liver fibrosis in patients with chronic liver disease.
Tangkijvanich P; Kongtawelert P; Pothacharoen P; Mahachai V; Suwangool P; Poovorawan Y
Asian Pac J Allergy Immunol; 2003 Jun; 21(2):115-20. PubMed ID: 14629129
[TBL] [Abstract][Full Text] [Related]
20. Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection?
Sanai FM; Benmousa A; Al-Hussaini H; Ashraf S; Alhafi O; Abdo AA; Alameri HF; Akbar HO; Bzeizi KI
Liver Int; 2008 Aug; 28(7):1011-8. PubMed ID: 18384520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
